栄養補助食品とワクチンの市場規模、シェア、成長分析：製品タイプ別、用途別、製剤タイプ別、流通チャネル別、地域別 - 産業予測 2025～2032年

世界の栄養補助食品とワクチン市場規模は2023年に570億4,000万米ドルと評価され、2024年の613億8,000万米ドルから2032年には1,102億8,000万米ドルに成長する見通しで、予測期間（2025～2032年）のCAGRは7.6%です。

世界の栄養補助食品とワクチン市場は、消費者の意識の高まりと健康とウェルネスへの関心の高まりに後押しされて力強い成長を遂げています。機能性食品や栄養補助食品を含む栄養補助食品は、その予防的な健康効果がますます求められています。同時にワクチン分野も、ワクチン技術の進歩や、普遍的なワクチン接種を奨励するWHOの世界ワクチン行動計画のようなイニシアティブに支えられた包括的な予防接種プログラムによって活況を呈しています。政府とNGOの関与に支えられた予防接種の急増は、公衆衛生全体を強化し、市場の成長を促しています。高血圧や糖尿病などの疾病を予防する役割が認められている栄養補助食品に対する需要の増加は、積極的な健康管理への社会のシフトを反映したものであり、最終的には医療費の削減と健康の増進につながります。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

栄養補助食品とワクチン市場規模：製品タイプ別& CAGR（2025-2032）

• 市場概要
• ワクチン
• 栄養補助食品

栄養補助食品とワクチン市場規模：用途別& CAGR（2025-2032）

• 市場概要
• スポーツ栄養
• 一般的な健康
• 免疫と消化器の健康
• 骨と関節の健康
• 心臓の健康
• 病気の予防
• 体重減少

栄養補助食品とワクチン市場規模：製剤タイプ別& CAGR（2025-2032）

• 市場概要
• タブレット
• カプセル
• 粉末
• 液体

栄養補助食品とワクチン市場規模：流通チャネル別& CAGR（2025-2032）

• 市場概要
• 病院薬局
• 小売薬局
• オンライン販売
• スーパーマーケット

栄養補助食品とワクチン市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• GlaxoSmithKline plc（GSK）（United Kingdom）
• Pfizer Inc.（United States）
• Sanofi Pasteur（France）
• Merck & Co., Inc.（United States）
• Moderna, Inc.（United States）
• Novavax, Inc.（United States）
• CSL Limited（Australia）
• AstraZeneca plc（United Kingdom）
• Johnson & Johnson（United States）
• Bavarian Nordic A/S（Denmark）

結論と提言

Global Nutraceutical &Vaccine Market size was valued at USD 57.04 billion in 2023 and is poised to grow from USD 61.38 billion in 2024 to USD 110.28 billion by 2032, growing at a CAGR of 7.6% during the forecast period (2025-2032).

The global nutraceutical and vaccine market is experiencing robust growth propelled by heightened consumer awareness and a growing focus on health and wellness. Nutraceuticals, including functional foods and dietary supplements, are increasingly sought after for their preventive health benefits. Simultaneously, the vaccine sector is booming due to advancements in vaccine technology and comprehensive immunization programs, supported by initiatives like WHO's Global Vaccine Action Plan, which encourages universal vaccination access. This surge in immunization, backed by both government and NGO involvement, is enhancing overall public health and fostering market growth. The increasing demand for nutraceuticals, recognized for their role in preventing diseases such as hypertension and diabetes, mirrors society's shift towards proactive health management, ultimately reducing healthcare costs and promoting well-being.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nutraceutical &Vaccine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nutraceutical &Vaccine Market Segments Analysis

Global Nutraceutical & Vaccine Market is segmented by Product Type, Application, Formulation Type, Distribution Channel and region. Based on Product Type, the market is segmented into Vaccines and Dietary Supplements. Based on Application, the market is segmented into Sports Nutrition, General Well-Being, Immune & Digestive Health, Bone & Joint Health, Heart Health, Disease Prevention and Weight loss. Based on Formulation Type, the market is segmented into Tablets, Capsules, Powders and Liquids. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Sales and Super Markets. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Nutraceutical &Vaccine Market

A key driver in the global nutraceutical and vaccine market is the heightened focus on preventive healthcare. As awareness of the significance of overall well-being and disease prevention expands, there is a growing demand for products that provide health benefits and bolster the immune system. Consumers are increasingly turning to nutraceuticals and vaccines to adopt a proactive approach to their health. This trend is propelled by various factors, including changing lifestyles, an aging population, and the collective desire to cut healthcare costs by prioritizing disease prevention over treatment. This shift underscores the market's potential for growth and innovation.

Restraints in the Global Nutraceutical &Vaccine Market

A significant challenge facing the global nutraceutical and vaccine market is the stringent regulatory frameworks and approval processes that govern their development and commercialization. These regulations mandate extensive testing, clinical trials, and regulatory clearances to ensure that products meet required safety, efficacy, and quality standards. Such rigorous procedures can often be lengthy and expensive, creating obstacles for market participants, particularly smaller companies with constrained resources. Additionally, these stringent requirements can lead to delays in product launches and heightened compliance costs, ultimately stifling growth and innovation within the nutraceutical and vaccine industries.

Market Trends of the Global Nutraceutical &Vaccine Market

A significant market trend in the global nutraceutical and vaccine sector is the rising demand for personalized and targeted healthcare solutions. Consumers are becoming more health-conscious and are actively seeking products specifically designed to meet their unique health needs and genetic profiles. This trend is primarily driven by technological advancements in genomics, personalized medicine, and data analytics, enabling the creation of customized nutrition and vaccination options. Industry players are increasingly investing in the development of tailored nutraceuticals and vaccines, offering bespoke formulations that cater to individual health concerns and enhance therapeutic outcomes. This movement signifies a pivotal shift towards precision healthcare, acknowledging the importance of individual health variations.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Nutraceutical & Vaccine Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Vaccines
• Dietary Supplements

Global Nutraceutical & Vaccine Market Size by Application & CAGR (2025-2032)

• Market Overview
• Sports Nutrition
• General Well-Being
• Immune & Digestive Health
• Bone & Joint Health
• Heart Health
• Disease Prevention
• Weight loss

Global Nutraceutical & Vaccine Market Size by Formulation Type & CAGR (2025-2032)

• Market Overview
• Tablets
• Capsules
• Powders
• Liquids

Global Nutraceutical & Vaccine Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Sales
• Super Markets

Global Nutraceutical & Vaccine Market Size & CAGR (2025-2032)

• North America (Product Type, Application, Formulation Type, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Application, Formulation Type, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, Formulation Type, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, Formulation Type, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, Formulation Type, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• GlaxoSmithKline plc (GSK) (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi Pasteur (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Moderna, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novavax, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bavarian Nordic A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations